Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Zero Based Budgeting During Financial Hardship helps you allocate every dollar during tough periods. Create a precise plan to curb waste and maintain essential spending with confidence.
24,373 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Dell Technologies reports a 10% decline in global staff for the third consecutive year, trimming roughly 11,000 jobs ...
Celo Foundation is awarding Opera a one-time grant of 160 million CELO tokens to strengthen its long-term Web3 strate...
Interloom just raised $16.5 million to convert tacit knowledge into AI-driven workflow tools. The Munich startup says...
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
A rising wave of spoof calls impersonating bank staff and law enforcement is draining customer accounts. Authorities ...
Nasdaq welcomes the 21Shares Canton Network ETF, the latest milestone in the ongoing crypto ETF surge. The fund aims ...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
Poly Truth is rolling out an AI-powered intelligence layer for prediction markets, promising data-driven insights on ...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Redwire stock jumped on intraday momentum before giving back gains. This article unpacks the forces behind the pop-a...
Microsoft’sAI push fuels cloud and enterprise gains even as capital outlays rise and OpenAI losses widen. Analysts ma...